Protein tyrosine phosphatases: Prospects for therapeutics

Current Opinion in Chemical Biology

Volumn 5, Issue 4, 2001, Pages 416-423

  Zhang, Zhong Yin ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR;

CATALYSIS; DIABETES MELLITUS; DRUG EFFECT; DRUG IDENTIFICATION; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME INHIBITION; HUMAN; KNOCKOUT GENE; NONHUMAN; OBESITY; PROTEIN DOMAIN; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0035415662     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00223-4     Document Type: Review

References (61)

1. Signaling - 2000 and beyond
2. The development and therapeutic potential of protein kinase inhibitors
3. Protein tyrosine phosphatases in signal transduction
4. Genetic analysis of protein tyrosine phosphatases
5. Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases
6. Initial sequencing and analysis of the human genome
7. Protein-tyrosine phosphatases: Biological function, structural characteristics, and mechanism of catalysis
8. An RNA 5′-triphosphatase related to the protein tyrosine phosphatases
9. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
10. Structural studies of reversible protein phosphorylation and protein phosphatases
11. Mutations at the murine motheaten locus are within the hematopoietic cell protein tyrosine phosphatase (hcph) gene
12. Genetic evidence that Shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals
13. The multiple roles of PTEN in tumor suppression
14. The lipid phosphatase activity of PTEN is critical for its tumor supressor function
15. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate
16. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway
17. Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy
18. Laforin, defective in the progressive myoclonus epilepsy of lafora type, is a dual-specificity phosphatase associated with polyribosomes
19. Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant
20. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium
21. The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro
22. Regulation of insulin action by protein tyrosine phosphatases
23. Protein tyrosine phosphatases: Their roles in insulin action and potential as drug targets
24. Protein tyrosine phosphatases (PTPs) as drug targets: Inhibitors of PTP1B for the treatment of diabetes
25. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
26. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice
27. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts
28. Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn
29. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase
30. Cdc25 phosphatases as potential human oncogenes
31. Role of Cdc25A phosphatase in human breast cancer
32. Cdc25 as a potential target of anticancer agents
33. FAP-1: A protein tyrosine phosphatase that associates with Fas
34. Identification of IκBα as a substrate of Fas-associated phosphatase-1
35. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation
36. Prevention and reversal of renal allograft rejection by antibody against CD45RB
37. A neuronal protein tyrosine phosphatase induced by nerve growth factor
38. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif
39. Dual specificity phosphatases: A gene family for control of MAP kinase function
40. Downregulation of LAR tyrosine phosphatase prevents apoptosis and augments NGF-induced neurite outgrowth
41. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
42. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B
43. Structural basis of plasticity in protein tyrosine phosphatase 1b substrate recognition
44. Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1
45. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B
46. Structure, mechanism and specificity of protein-tyrosine phosphatases
47. Assessment of protein tyrosine phosphatase 1B substrate specificity using 'inverse alanine scanning'
48. Protein tyrosine phosphatases: Structure, mechanism and inhibitor discovery
49. PTP1B Inhibition and antihyperglycemic activity of novel 11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes
50. Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties
51. Structure-based discovery of small molecule inhibitors targeted to protein tyrosine phosphatase 1B
52. Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B
53. Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design
54. Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B
55. Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases
56. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signaling transduction
57. The next wave: Protein tyrosine phosphatases enter T cell antigen receptor signalling
58. Protein-tyrosine phosphatase activity regulates osteoclast formation and function: Inhibition by alendronate
59. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance
60. Enantioselective synthesis of nonphosphorous-containing phosphotyrosyl mimetics and their use in the preparation of tyrosine phosphatase inhibitory peptides
61. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1b and augment insulin action